Clinical Trials

Supraventricular tachycardia

Displaying 2 studies

A Study to Evaluate the Effectiveness and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT) Rochester, MN

The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of Paroxysmal Supraventricular Tachycardia (PSVT) in an outpatient setting.
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301 Rochester, MN

The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an outpatient setting.